Abstract
The Sleeping Beauty (SB) transposon is a promising technology platform for gene transfer in vertebrates; however, its efficiency of gene insertion can be a bottleneck in primary cell types. A large-scale genetic screen in mammalian cells yielded a hyperactive transposase (SB100X) with ∼100-fold enhancement in efficiency when compared to the first-generation transposase. SB100X supported 35–50% stable gene transfer in human CD34+ cells enriched in hematopoietic stem or progenitor cells. Transplantation of gene-marked CD34+ cells in immunodeficient mice resulted in long-term engraftment and hematopoietic reconstitution. In addition, SB100X supported sustained (>1 year) expression of physiological levels of factor IX upon transposition in the mouse liver in vivo. Finally, SB100X reproducibly resulted in 45% stable transgenesis frequencies by pronuclear microinjection into mouse zygotes. The newly developed transposase yields unprecedented stable gene transfer efficiencies following nonviral gene delivery that compare favorably to stable transduction efficiencies with integrating viral vectors and is expected to facilitate widespread applications in functional genomics and gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ivics, Z., Hackett, P.B., Plasterk, R.H. & Izsvák, Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91, 501–510 (1997).
Mates, L., Izsvak, Z. & Ivics, Z. Technology transfer from worms and flies to vertebrates: transposition-based genome manipulations and their future perspectives. Genome Biol. 8 (Suppl 1), S1 (2007).
Ivics, Z. & Izsvak, Z. Transposons for gene therapy! Curr. Gene Ther. 6, 593–607 (2006).
Geurts, A.M. et al. Gene transfer into genomes of human cells by the Sleeping Beauty transposon system. Mol. Ther. 8, 108–117 (2003).
Zayed, H., Izsvak, Z., Walisko, O. & Ivics, Z. Development of hyperactive Sleeping Beauty transposon vectors by mutational analysis. Mol. Ther. 9, 292–304 (2004).
Baus, J., Liu, L., Heggestad, A.D., Sanz, S. & Fletcher, B.S. Hyperactive transposase mutants of the Sleeping Beauty transposon. Mol. Ther. 12, 1148–1156 (2005).
Yant, S.R., Park, J., Huang, Y., Mikkelsen, J.G. & Kay, M.A. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells. Mol. Cell. Biol. 24, 9239–9247 (2004).
Cadinanos, J. & Bradley, A. Generation of an inducible and optimized piggyBac transposon system. Nucleic Acids Res. 35, e87 (2007).
Wilson, M.H., Coates, C.J. & George, A.L. Jr. PiggyBac Transposon-mediated Gene Transfer in Human Cells. Mol. Ther. 15, 139–145 (2007).
Wang, W. et al. Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 105, 9290–9295 (2008).
Izsvak, Z. & Ivics, Z. Sleeping beauty transposition: biology and applications for molecular therapy. Mol. Ther. 9, 147–156 (2004).
Liu, G., Aronovich, E.L., Cui, Z., Whitley, C.B. & Hackett, P.B. Excision of Sleeping Beauty transposons: parameters and applications to gene therapy. J. Gene Med. 6, 574–583 (2004).
Mingozzi, F. et al. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J. Clin. Invest. 111, 1347–1356 (2003).
Conner, D.A. Transgenic mouse production by zygote injection. Curr. Protoc. Mol. Biol. Chapter 23, Unit 23.9 (2004).
Dupuy, A.J. et al. Mammalian germ-line transgenesis by transposition. Proc. Natl. Acad. Sci. USA 99, 4495–4499 (2002).
Horie, K. et al. Characterization of Sleeping Beauty transposition and its application to genetic screening in mice. Mol. Cell. Biol. 23, 9189–9207 (2003).
Kitada, K. et al. Transposon-tagged mutagenesis in the rat. Nat. Methods 4, 131–133 (2007).
Lu, B. et al. Generation of rat mutants using a coat color-tagged Sleeping Beauty transposon system. Mamm. Genome 18, 338–346 (2007).
Dupuy, A.J., Fritz, S. & Largaespada, D.A. Transposition and gene disruption in the male germline of the mouse. Genesis 30, 82–88 (2001).
Yusa, K., Takeda, J. & Horie, K. Enhancement of Sleeping Beauty transposition by CpG methylation: possible role of heterochromatin formation. Mol. Cell. Biol. 24, 4004–4018 (2004).
Geurts, A.M. et al. Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet. 2, e156 (2006).
Manno, C.S. et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342–347 (2006).
Hollis, R.P. et al. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon. Exp. Hematol. 34, 1333–1343 (2006).
Conneally, E., Eaves, C.J. & Humphries, R.K. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 91, 3487–3493 (1998).
Miyoshi, H., Smith, K.A., Mosier, D.E., Verma, I.M. & Torbett, B.E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682–686 (1999).
Salmon, P. et al. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 96, 3392–3398 (2000).
Follenzi, A., Ailles, L.E., Bakovic, S., Geuna, M. & Naldini, L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25, 217–222 (2000).
VandenDriessche, T. et al. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100, 813–822 (2002).
Zufferey, R., Donello, J.E., Trono, D. & Hope, T.J. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886–2892 (1999).
Piacibello, W. et al. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient. Blood 100, 4391–4400 (2002).
Bushman, F. et al. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3, 848–858 (2005).
Schroder, A.R. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521–529 (2002).
Liu, G. et al. Target-site preferences of Sleeping Beauty transposons. J. Mol. Biol. 346, 161–173 (2005).
Vigdal, T.J., Kaufman, C.D., Izsvák, Z., Voytas, D.F. & Ivics, Z. Common physical properties of DNA affecting target site selection of Sleeping Beauty and other Tc1/mariner transposable elements. J. Mol. Biol. 323, 441–452 (2002).
Ivics, Z. et al. Targeted Sleeping Beauty transposition in human cells. Mol. Ther. 15, 1137–1144 (2007).
Yant, S.R., Huang, Y., Akache, B. & Kay, M.A. Site-directed transposon integration in human cells. Nucleic Acids Res. 35, e50 (2007).
Walisko, O. et al. Transcriptional activities of the Sleeping Beauty transposon and shielding its genetic cargo with insulators. Mol. Ther. 16, 359–369 (2008).
Dalsgaard, T. et al. Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells. Mol. Ther. 17, 121–130 (2009).
Mikkelsen, J.G. et al. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mol. Ther. 8, 654–665 (2003).
Ohlfest, J.R. et al. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood 105, 2691–2698 (2005).
Yant, S.R. et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 25, 35–41 (2000).
Stemmer, W.P. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. USA 91, 10747–10751 (1994).
Miao, C.H. et al. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol. Ther. 1, 522–532 (2000).
Ishikawa, F. et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106, 1565–1573 (2005).
Nagy, A., Gertsenstein, M., Vintersten, K. & Behringer, R. Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2003).
Moore, J.C., Jin, H.M., Kuchner, O. & Arnold, F.H. Strategies for the in vitro evolution of protein function: enzyme evolution by random recombination of improved sequences. J. Mol. Biol. 272, 336–347 (1997).
Acknowledgements
We thank C. Judis, V. Gillijns and M. Shrahna for technical assistance. Z. Izsvák is an EURYI Awardee. We acknowledge the financial support of EU FP5 (JUMPY), EU FP6 (INTHER) and EU FP7 (PERSIST), grants from the Volkswagen Stiftung and from the Bundesministerium für Bildung und Forschung (NGFN-2), VIB GOA/2004/09 and FWO (G.0632.07). We thank E. Zeira, E. Galun (Goldyne Savad Institute of Gene Therapy) and M. Rhee (Chunguam University of Korea) for providing the pT2/CAGGS-GFP and the pcGlobin2 constructs, respectively. We further thank M.J. Fraser (University of Notre Dame) and A. Bradley (Sanger Centre) for providing the pXL-BacII and codon-optimized piggyBac transposase constructs, respectively, and A. Leutz and N. Rajewsky for critical reading of the manuscript. A. Schmitt is affiliated with Medical Faculty of Charité, Berlin.
Author information
Authors and Affiliations
Contributions
L.M. designed the hyperactive screen and characterization of the hyperactive transposases, generated some of the hyperactive mutations, generated and screened the hyperactive library, and characterized the hyperactives in human HeLa cells and in transgenic mice, analyzed data and wrote the paper. M.K.L.C. designed, managed and performed the HSC and liver gene transfer experiments, analyzed data, wrote the paper and supervised the project. E.B. performed the transfections on the HSC and liver, did the in vivo transplantations, ELISA and analyzed data. B.J. contributed with animal work (microinjections and in vitro embryo culture). N.M. generated some of the hyperactive mutations. A.A.-S. generated the constructs and conducted the qPCR, excision assays and integration site analysis and analyzed data. D.P.G. analyzed the subcelluler localization of SB and SB100X transposases in response to heat shock. A.S. compared SB and SB100X for protein stability. K.B. contributed with mouse microinjections. J.M. did confocal microscopical analysis on HSC, bioinformatics, ELISA and analyzed data. L.M. optimized HSC transfections and did FACS. E.S.-K. did in vivo transfections and stem cell culture experiments. C.G. did HSC transplantation experiments in vivo. D.P. compared SB and SB100X for DNA binding. C.M. isolated common insertion sites from hematopoietic lineages by LAM-PCR. B.F. generated some of the hyperactive mutations. T.V. designed and managed the experiments on the HSC and liver gene transfer, analyzed data, supervised the project and wrote the paper. Z. Ivics designed the hyperactive screen and characterization of the hyperactive transposases, analyzed and interpreted data, supervised the project and wrote the paper. Z. Izsvák designed the hyperactive screen and characterization of the hyperactive transposases, analyzed and interpreted data, supervised the project and wrote the paper.
Corresponding authors
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–8, Supplementary Tables 1–4 and Supplementary Methods (PDF 2454 kb)
Rights and permissions
About this article
Cite this article
Mátés, L., Chuah, M., Belay, E. et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat Genet 41, 753–761 (2009). https://doi.org/10.1038/ng.343
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.343
This article is cited by
-
Mobility of mPing and its associated elements is regulated by both internal and terminal sequences
Mobile DNA (2023)
-
An electrogenetic interface to program mammalian gene expression by direct current
Nature Metabolism (2023)
-
AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells
Nature Biomedical Engineering (2023)
-
Combinatorial protein dimerization enables precise multi-input synthetic computations
Nature Chemical Biology (2023)
-
Androgen receptor variant 7 exacerbates hepatocarcinogenesis in a c-MYC-driven mouse HCC model
Oncogenesis (2023)